Lantheus Reports Q1 2026 Earnings with Mixed Financial Results
Lantheus (LNTH) reported mixed financial results for the first quarter of 2026, including a slight revenue increase and declines in oncology revenue. The company experienced growth in neurology and cardiology segments but faced margin pressures from acquisitions and pricing challenges.
